Regent Investment Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-20,922
| Closed | -$94K | – | 212 |
|
|
2022
Q1 | $94K | Sell |
20,922
-4,078
| -16% | -$18.3K | 0.02% | 209 |
|
|
2021
Q4 | $170K | Hold |
25,000
| – | – | 0.04% | 216 |
|
|
2021
Q3 | $182K | Hold |
25,000
| – | – | 0.04% | 210 |
|
|
2021
Q2 | $251K | Buy |
25,000
+2,000
| +9% | +$20.1K | 0.06% | 189 |
|
|
2021
Q1 | $220K | Buy |
23,000
+3,000
| +15% | +$28.7K | 0.06% | 191 |
|
|
2020
Q4 | $219K | Buy |
+20,000
| New | +$219K | 0.06% | 179 |
|